Cargando…

Nebivolol Protects against Myocardial Infarction Injury via Stimulation of Beta 3-Adrenergic Receptors and Nitric Oxide Signaling

Nebivolol, third-generation β-blocker, may activate β3-adrenergic receptor (AR), which has been emerged as a novel and potential therapeutic targets for cardiovascular diseases. However, it is not known whether nebivolol administration plays a cardioprotective effect against myocardial infarction (M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zheng, Ding, Liping, Jin, Zhitao, Gao, Guojie, Li, Huijun, Zhang, Lijuan, Zhang, Lina, Lu, Xin, Hu, Lihua, Lu, Bingwei, Yu, Xiongjun, Hu, Taohong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029889/ https://www.ncbi.nlm.nih.gov/pubmed/24849208 http://dx.doi.org/10.1371/journal.pone.0098179

Ejemplares similares

Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)

Nitric oxide mediated the effects of nebivolol in cardiorenal syndrome
por: Mercanoglu, Guldem, et al.
Publicado: (2019)

Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction
por: Zhang, Zheng, et al.
Publicado: (2017)

Nebivolol Increases Nitric Oxide Synthase via β(3) Adrenergic Receptor in Endothelial Cells Following Exposure to Plasma from Preeclamptic Patients
por: Bueno-Pereira, Thaina Omia, et al.
Publicado: (2022)

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension
por: Li, Bingwei, et al.
Publicado: (2020)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats
por: Liu, Jiaqi, et al.
Publicado: (2017)

Adrenergic Blockade by Nebivolol to Suppress Oral Squamous Cell Carcinoma Growth via Endoplasmic Reticulum Stress and Mitochondria Dysfunction
por: Chen, Qian, et al.
Publicado: (2021)

Nebivolol versus Carvedilol or Metoprolol in Patients Presenting with Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction
por: Ozaydin, Mehmet, et al.
Publicado: (2016)

Effect of Low-Dose Nebivolol in Patients with Acute Myocardial Infarction: A Multi-Center Observational Study
por: Sim, Doo Sun, et al.
Publicado: (2020)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)

Nebivolol combined with tetrahydrobiopterin affects diastolic function in spontaneously hypertensive rats via the nitric oxide/cyclic guanosine monophosphate signalling pathway
por: Guan, Xiaoli, et al.
Publicado: (2020)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

Blockade of ß-Adrenergic Receptors by Nebivolol Enables Tumor Control Potential for Uveal Melanoma in 3D Tumor Spheroids and 2D Cultures
por: Farhoumand, Lina S., et al.
Publicado: (2023)

Effect of β1-adrenergic receptor gene polymorphism on ventricular arrhythmia and prognosis after myocardial infarction
por: Ran, Tao, et al.
Publicado: (2023)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells
por: Mason, R Preston, et al.
Publicado: (2013)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

Antioxidant Flavonoid Diosmetin Is Cardioprotective in a Rat Model of Myocardial Infarction Induced by Beta 1-Adrenergic Receptors Activation
por: Ahmad, Taseer, et al.
Publicado: (2023)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

At the Crossroads of Cardiac Beta-Adrenergic Receptor Signaling and Myocardial Glucose Metabolism
por: Kereliuk, Stephanie M., et al.
Publicado: (2023)

Beta-Adrenergic Agonists
por: Barisione, Giovanni, et al.
Publicado: (2010)

Beta2-adrenergic receptor agonist inhibits keratinocyte proliferation by mechanisms involving nitric oxide
por: Wu, Chieh-Shan, et al.
Publicado: (2020)

Irisin Attenuates Myocardial Ischemia/Reperfusion Injury and Improves Mitochondrial Function Through AMPK Pathway in Diabetic Mice
por: Xin, Chao, et al.
Publicado: (2020)

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
por: Schmidt, André C, et al.
Publicado: (2008)

The influence of new beta-adrenolytics nebivolol and carvedilol on intraocular pressure and iris blood flow in rabbits
por: Szumny, Dorota, et al.
Publicado: (2014)

Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Rhabdomyolysis in a patient taking nebivolol
por: Kim, Ye Jin, et al.
Publicado: (2016)

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms
por: quốc Lu’o’ng, Khanh vinh, et al.
Publicado: (2012)

Machine learning-based integration develops biomarkers initial the crosstalk between inflammation and immune in acute myocardial infarction patients
por: Li, Hongyu, et al.
Publicado: (2023)

Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension
por: Soanker, Radhika, et al.
Publicado: (2012)

Arterial stiffness, hypertension, and rational use of nebivolol
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2009)

A Review of Nebivolol Pharmacology and Clinical Evidence
por: Fongemie, Justin, et al.
Publicado: (2015)

Role of β-Adrenergic Receptors and Estrogen in Cardiac Repair after Myocardial Infarction: An Overview
por: Matarrese, Paola, et al.
Publicado: (2021)

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
por: Patel, Rachna S., et al.
Publicado: (2014)

Beta adrenergic antagonists and antianginal drugs
por: Stever, Lindsey M., et al.
Publicado: (2021)

Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021)

Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction
por: Hakalahti, Anna E, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_282k9bvo74qfd84cfdjssvqng0